The therapeutic potential of TRAIL receptor signalling in cancer cells.
about
Clinical perspectives of TRAIL: insights into central nervous system disordersIdentification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening.Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection.Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.Current status of gene therapy for brain tumors.Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas.Die and let live: harnessing BikDD to combat breast cancer stem cells.5,7-Dihydroxyflavone Enhances the Apoptosis-Inducing Potential of TRAIL in Human Tumor Cells via Regulation of Apoptosis-Related ProteinsTrastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells.Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia.Systemic tumor-specific gene delivery.Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells.An Approach to Breast Cancer Immunotherapy: The Apoptotic Activity of Recombinant Anti-Interleukin-6 Monoclonal Antibodies in Intact Tumour Microenvironment of Breast Carcinoma.Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide.Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors.Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells.Phage display-derived human antibodies in clinical development and therapyHuman embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms.Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
P2860
Q26766570-348FE3B2-41C0-4F79-B811-E24AB9B40A9AQ33739941-49259E94-328A-478F-8F40-CE353F4D63F6Q33910907-E0B8F333-A312-4895-A6E7-42A6D7AA68B3Q34260349-C0BB3B68-6222-46C5-90FE-5FE3CA651C4CQ34318157-650DDAA0-6A77-43DE-B399-2CF332DAF9F9Q35653261-AFAEBD74-6D30-4EE1-8B74-5F76E11B3778Q36245312-5510FF50-3A8E-49A2-B40E-517257D7FDA0Q36692259-A5F96113-0C82-4508-8E7C-86E1D03B8D88Q37099041-A48FA5BE-D088-477A-A64D-E9FB9253899CQ38068494-6DE3F3EA-4160-49BE-8FBB-F3068D8D6254Q38137609-28B6CADB-8AD9-4059-89A3-E7BCE9C2BF1AQ38726515-CE23F674-1C36-4156-8CFC-FB079D7419A4Q38786771-DC44606E-581A-4B35-84FE-803304259938Q38895190-9CF9FEF2-23C3-4343-A5B7-015D916403A0Q39066974-3C7B2899-1075-4291-B770-6CAD36C09B9DQ40947112-0695F172-8A65-4A30-9F46-E04A38A2B3C9Q41416393-0C8DF589-18A0-4AA6-A1CE-24786C2CBF6CQ42915261-7BC85F42-BF3A-493D-B519-D4BAAEC3D3C3Q43468001-EA046DDA-7904-46D2-BD36-170F2929908BQ47620185-660CF156-9D2C-4EEB-B66D-27CAB4B61223Q53560998-7EF46DDC-53C9-485E-8AA9-166933B88F3B
P2860
The therapeutic potential of TRAIL receptor signalling in cancer cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The therapeutic potential of TRAIL receptor signalling in cancer cells.
@en
The therapeutic potential of TRAIL receptor signalling in cancer cells.
@nl
type
label
The therapeutic potential of TRAIL receptor signalling in cancer cells.
@en
The therapeutic potential of TRAIL receptor signalling in cancer cells.
@nl
prefLabel
The therapeutic potential of TRAIL receptor signalling in cancer cells.
@en
The therapeutic potential of TRAIL receptor signalling in cancer cells.
@nl
P2860
P50
P1476
The therapeutic potential of TRAIL receptor signalling in cancer cells
@en
P2093
A López-Rivas
P2860
P2888
P304
P356
10.1007/S12094-011-0744-4
P577
2011-12-01T00:00:00Z